The role of galectin-3 in obese patients with heart failure

被引：0
|
作者：
Dadarlat, A. [1 ]
Pop, D. [1 ]
Zdrenghea, D. [1 ]
Bodisz, G. [2 ]
Fringu, F. [1 ]
Gurzau, D. [1 ]
Susca-Hjoda, S. [1 ]
Buzoianu, A. D. [1 ]
机构：
[1] Univ Med & Pharm, Cluj Napoca, Romania
[2] Rehabil Hosp, Cluj Napoca, Romania
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P336
引用
收藏
页码：70 / 70
页数：1
相关论文
共 50 条
  • [21] Galectin-3 as a Marker of Cardiorenal Syndrome in Patients with Chronic Heart Failure
    Podzolkov, V. I.
    Dragomiretskaya, N. A.
    Beliaev, I. G.
    Kazadaeva, A. V.
    Tolmacheva, A. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2022, 18 (02) : 153 - 159
  • [22] Prognostic uility of galectin-3 in Vietnamese patients with acute heart failure
    Toan, Dang
    Huong, Ta
    Hoang, S. Y.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 27 - 27
  • [23] Association of Urine Galectin-3 With Cardiorenal Outcomes in Patients With Heart Failure
    Rao, Veena S.
    Ivey-Miranda, Juan B.
    Cox, Zachary L.
    Moreno-Villagomez, Julieta
    Testani, Jeffrey M.
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (02) : 340 - 346
  • [24] Galectin-3 in heart failure patients: marker or mediator of renal insufficiency?
    Zamora, E.
    Lupon, J.
    De Antonio, M.
    Galan, A.
    Domingo, M.
    Urrutia, A.
    Gonzalez, B.
    Diez, C.
    Troya, M.
    Bayes-Genis, A.
    EUROPEAN HEART JOURNAL, 2014, 35 : 14 - 14
  • [25] Predictive value of plasma galectin-3 in patients with chronic heart failure
    Chen, K.
    Jiang, R. -J.
    Wang, C. -Q.
    Yin, Z. -F.
    Fan, Y. -Q.
    Cao, J. -T.
    Han, Z. -H.
    Wang, Y.
    Song, D. -Q.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (08) : 1005 - 1011
  • [26] Galectin-3: A Modifiable Risk Factor in Heart Failure
    de Boer, Rudolf A.
    van der Velde, A. Rogier
    Mueller, Christian
    van Veldhuisen, Dirk J.
    Anker, Stefan D.
    Peacock, W. Frank
    Adams, Kirkwood F.
    Maisel, Alan
    CARDIOVASCULAR DRUGS AND THERAPY, 2014, 28 (03) : 237 - 246
  • [27] Erratum to: Galectin-3 in Cardiac Remodeling and Heart Failure
    Rudolf A. de Boer
    Lili Yu
    Dirk J. van Veldhuisen
    Current Heart Failure Reports, 2012, 9 (3) : 163 - 163
  • [28] Galectin-3: A Modifiable Risk Factor in Heart Failure
    Rudolf A. de Boer
    A. Rogier van der Velde
    Christian Mueller
    Dirk J. van Veldhuisen
    Stefan D. Anker
    W. Frank Peacock
    Kirkwood F. Adams
    Alan Maisel
    Cardiovascular Drugs and Therapy, 2014, 28 : 237 - 246
  • [29] Personalizing biomarker strategies in heart failure with galectin-3
    Sherwi, Nasser
    Merali, Shermin
    Wong, Kenneth
    FUTURE CARDIOLOGY, 2012, 8 (06) : 885 - 894
  • [30] Practical experience using galectin-3 in heart failure
    McCullough, Peter A.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (10) : 1425 - 1431
12345